Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and mammalian target of rapamycin

American Journal of Pathology

Volumn 170, Issue 1, 2007, Pages 301-315

  Schaefer, Liliana ^a,b   Tsalastra, Wasiliki ^a   Babelova, Andrea ^a   Baliova, Martina ^a   Minnerup, Jens ^a   Sorokin, Lydia ^a   Gröne, Hermann Josef ^c   Reinhardt, Dieter P ^d   Pfeilschifter, Josef ^b   Iozzo, Renato V ^e   Schaefer, Roland M ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d MCGILL UNIVERSITY   (Canada)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; FIBRILLIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; S6 KINASE; SOMATOMEDIN C RECEPTOR; ACTIN BINDING PROTEIN; FIBRILLIN; PROTEIN KINASE; PROTEOGLYCAN; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KIDNEY FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; URETER OBSTRUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FIBROBLAST; FIBROSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; KIDNEY DISEASE; METABOLISM;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; PROTEIN BINDING; PROTEIN KINASES; PROTEOGLYCANS; RATS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 33847051740     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060497     Document Type: Article

References (51)

1. Iozzo RV: The biology of the small leucine-rich proteoglycans: functional network of interactive proteins. J Biol Chem 1999, 274:18843-18846
2. Reed CC, Iozzo RV: The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J 2003, 19:249-255
3. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997, 136:729-743
4. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E: Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994, 302:527-534
5. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992, 360:361-364
6. Schaefer L, Raslik I, Gröne HJ, Schönherr E, Macakova K, Ugorcakova J, Budny S, Schaefer RM, Kresse H: Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J 2001, 15:559-561
7. Kresse H, Schönherr E: Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001, 189:266-274
8. De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV: Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 1996, 271: 18961-18965
9. Patel S, Santra M, McQuillan DJ, Iozzo RV, Thomas AP: Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells. J Biol Chem 1998, 273:3121-3124
10. Santra M, Reed CC, Iozzo RV: Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J Biol Chem 2002, 277:35671-35681
11. Schönherr E, Sunderkotter C, Iozzo RV, Schaefer L: Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 2005, 280:15767-15772
12. Schönherr E, Levkau B, Schaefer L, Kresse H, Walsh K: Decorin-mediated signal transduction in endothelial cells: involvement of Akt/ protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J Biol Chem 2001, 276:40687-40692
13. Vincent AM, Feldman EL: Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 2002, 12:193-197
14. Shahbazian D, Roux PP, Mieulet V, Cohen MS, Raught B, Taunton J, Hershey JW, Blenis J, Pende M, Sonenberg N: The mTOR/PI3K and MAPK pathways converge on elF4B to control its phosphorylation and activity. EMBO J 2006, 25:2781-2791
15. Wullschleger S, Loewith R, Hall MN: TOR signaling in growth and metabolism. Cell 2006, 124:471-484
16. Granville CA, Memmott RM, Gills JJ, Dennis PA: Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/ mammalian target of rapamycin pathway. Clin Cancer Res 2006, 12:679-689
17. Zhu J, Wu J, Frizell E, Liu SL, Bashey R, Rubin R, Norton P, Zern MA: Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology 1999, 117:1198-1204
18. Shegogue D, Trojanowska M: Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway. J Biol Chem 2004, 279:23166-23175
19. Romanelli A, Martin KA, Toker A, Blenis J: p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol Cell Biol 1999, 19:2921-2928
20. Schaefer L, Mihalik D, Babelova A, Krzyzankova M, Gröne HJ, Iozzo RV, Young MF, Seidler DG, Lin G, Reinhardt DP, Schaefer RM: Regulation of fibrillin-1 by biglycan and decorin is important for tissue preservation in the kidney during pressure-induced injury. Am J Pathol 2004, 165:383-396
21. Pulkkinen L, Kainulainen K, Krusius T, Makinen P, Schollin J, Gustavsson KH, Peltonen L: Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. J Biol Chem 1990, 265:17780-17785
22. Superti-Furga A, Raghunath M, Willems PJ: Deficiencies of fibrillin and decorin in fibroblast cultures of a patient with neonatal Marfan syndrome. J Med Genet 1992, 29:875-878
23. Trask BC, Trask TM, Broekelmann T, Mecham RP: The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin. Mol Biol Cell 2000, 11:1499-1507
24. Sterzel RB, Hartner A, Schlotzer-Schrehardt U, Voit S, Hausknecht B, Doliana R, Colombatti A, Gibson MA, Braghetta P, Bressan GM: Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture. Kidney Int 2000, 58:1588-1602
25. Kissin EY, Lemaire R, Korn JH, Lafyatis R: Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation. Arthritis Rheum 2002, 46:3000-3009
26. Bouzeghrane F, Reinhardt DP, Reudelhuber TL, Thibault G: Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis. Am J Physiol Heart Circ Physiol 2005, 289:H982-H991
27. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312:117-121
28. Kenney MC, Zorapapel N, Atilano S, Chwa M, Ljubimov A, Brown D: Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta (TGF-beta) modulate tenascin-C and fibrillin-1 in bullous keratopathy stromal cells in vitro. Exp Eye Res 2003, 77:537-546
29. Tiedemann K, Batge B, Müller PK, Reinhardt DP: Interactions of fibrillin-1 with heparin/heparan sulfate, implications for microfibrillar assembly. J Biol Chem 2001, 276:36035-36042
30. Hausser H, Ober B, Quentin-Hoffmann E, Schmidt B, Kresse H: Endocytosis of different members of the small chondroitin/dermatan sulfate proteoglycan family. J Biol Chem 1992, 267:11559-11564
31. Fisher LW, Stubbs JT III, Young MF: Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl 1995, 266:61-65
32. Kresse H, Liszio C, Schönherr E, Fisher LW: Critical role of glutamate in a central leucine-rich repeat of decorin for interaction with type I collagen. J Biol Chem 1997, 272:18404-18410
33. Schaefer L, Beck KF, Raslik I, Walpen S, Mihalik D, Micegova M, Macakova K, Schönherr E, Seidler DG, Varga G, Schaefer RM, Kresse H, Pfeilschifter J: Biglycan, a nitric oxide-regulated gene, affects adhesion, growth, and survival of mesangial cells. J Biol Chem 2003, 278:26227-26237
34. Glössl J, Beck M, Kresse H: Biosynthesis of proteodermatan sulfate in cultured human fibroblasts. J Biol Chem 1984, 259:14144-14150
35. Schaefer L, Macakova K, Raslik I, Micegova M, Gröne HJ, Schönherr E, Robenek H, Echtermeyer FG, Grassel S, Bruckner P, Schaefer RM, Iozzo RV, Kresse H: Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 2002, 160:1181-1191
36. Garvey W: Modified elastic tissue-Masson trichrome stain. Stain Technol 1984, 59:213-216
37. Gröne HJ, Cohen CD, Gröne E, Schmidt C, Kretzler M, Schlöndorff D, Nelson PJ: Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney. J Am Soc Nephrol 2002, 13:957-967
38. Santra M, Eichstetter I, Iozzo RV: An anti-oncogenic role for decorin: down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem 2000, 275:35153-35161
39. Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, Schreiber SL: Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature 1995, 377:441-446
40. Bascands JL, Schanstra JP: Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 2005, 68:925-937
41. Weng QP, Kozlowski M, Belham C, Zhang A, Comb MJ, Avruch J: Regulation of the p70 S6 kinase by phosphorylation in vivo: analysis using site-specific anti-phosphopeptide antibodies. J Biol Chem 1998, 273:16621-16629
42. Ruvinsky I, Meyuhas O: Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 2006, 31:342-348
43. Diamond JR, Ricardo SD, Klahr S: Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin Nephrol 1998, 18:594-602
44. Klahr S: Obstructive nephropathy. Intern Med 2000, 39:355-361
45. Diamond JR: Macrophages and progressive renal disease in experimental hydronephrosis. Am J Kidney Dis 1995, 26:133-140
46. Dixon R, Brunskill NJ: Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: implications for the pathophysiology of proteinuric states. J Am Soc Nephrol 1999, 10:1487-1497
47. Pallet N, Thervet E, Le Corre D, Knebelmann B, Nusbaum P, Tomkiewicz C, Meria P, Flinois JP, Beaune P, Legendre C, Anglicheau D: Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability. Kidney Int 2005, 67:2422-2433
48. Morris RE, Cao W, Huang X, Gregory CR, Billingham ME, Rowan R, Shorthouse RA: Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells. Transplant Proc 1995, 27:430-431
49. Stallone G, Infante B, Schena A, Battaglia M, Ditonno P, Loverre A, Gesualdo L, Schena FP, Grandaliano G: Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol 2005, 16:3755-3762
50. Svegliati-Baroni G, Ridolfi F, Di Sario A, Saccomanno S, Bendia E, Benedetti A, Greenwel P: Intracellular signaling pathways involved in acetaldehyde-induced collagen and fibronectin gene expression in human hepatic stellate cells. Hepatology 2001, 33:1130-1140
51. Kim MS, Park J, Ha H, Kim YS, Kang SW, Jeong HJ, Kang DH, Yang CW: Rapamycin inhibits platelet-derived growth factor-induced collagen, but not fibronectin, synthesis in rat mesangial cells. Yonsei Med J 2004, 45:1121-1126